Pine Tree Equity Recapitalizes Chemistry Rx
Pine Tree Equity IV, LP (“Pine Tree Equity”), a private equity firm based in Miami, FL, is pleased to announce that it has recapitalized Madame Rx, LLC d/b/a Chemistry Rx (collectively “Chemistry Rx” or the “Company”) in March 2021. The Company, founded in 2013 and headquartered in Folcroft, PA, is a leading provider of pharmacy compounding services, with a focus on rare, pediatric dermatological and metabolic medications. Chemistry Rx operates a 503A pharmacy that produces prescriptions customized for, and specific to, individual patients. For additional information on Chemistry Rx, please visit www.chemistryrx.com.
Pine Tree Equity partnered with the founder and management team of Chemistry Rx to recapitalize the platform in order to accelerate the Company’s geographic expansion and pursue complementary add-on acquisitions. Chemistry Rx marks Pine Tree Equity’s 83rd investment since inception in 2007 (i.e., 28 platform and 55 add-on acquisitions). We are pleased to offer traditional referral fees for a closed transaction based on a signed fee agreement. For additional information, please call Austin Murphy at (305) 808-9820.
